A rare alliance between Steve Bannon and Senator Ron Wyden highlights concerns over President Trump's financial ties to major AI firms, suggesting that these connections jeopardize national security and complicate regulatory efforts.
In a surprising twist in the battle for Democratic hearts and minds, Hawaii's centrist incumbents have triumphed over their progressive challengers, further complicating the party…
The ongoing transformation at CBS News under Bari Weiss has left '60 Minutes' at a crossroads, raising questions about the integrity of its investigative journalism and the future…
In a bold move to capture the tech-savvy electorate, the White House has launched the 'AI Sovereignty' initiative, aiming to position the administration as a champion of ethical A…
One Nation's recent media bans demonstrate a troubling trend in political accountability as they reshape press freedom rules, all while the mainstream media responds with tepid di…
FIFA's audacious plan to sell a stake in World Cup rights has sparked global outrage, leading to questions about governance and commercial ethics. This satirical piece explores th…
In a shocking turn of events, Kansas voters are faced with an amendment that promises 'democracy' while billionaire interests pull the strings behind the scenes. The Koch-Leo duo…
In a shocking twist, Trump’s MAGA agenda has betrayed its own health movement, MAHA, as it embraces Big Agriculture and Big Pharma over public health. The conflict raises eyebrows…
In a stunning display of fiscal responsibility, Oracle has secured a $7 billion contract with the Pentagon, promising to improve military software while simultaneously boosting it…
As data centers proliferate across America amidst an AI frenzy, local communities are rising up against the environmental and health risks posed by these digital fortresses. Activ…
The recent AI shutdowns have revealed the government's knack for overreach, turning tech regulation into a chaotic game of whack-a-mole. With officials juggling national security…
In a bold move that could shake the foundations of pharmaceutical pricing, Colorado's attempt to cap drug prices faces the wrath of Amgen and a federal court. As the battle for af…